WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers

WuXi AppTec

Capacity Expansion

WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-the-Art Testing Laboratory

WuXi AppTec

CAR-T Cell Therapy

WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform

WuXi Advanced Therapies

Expanded Capacity

WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility

WuXi STA

M&A

WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development

WuXi AppTec

Healthcare

The First WuXi Healthcare Forum Opens in Shanghai

WuXi AppTec

Awards

WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan

WuXi AppTec

Announcement

WuXi AppTec Group and Mayo Clinic Receive 2018 MedTech Insight Award for Best Alliance

WuXi AppTec

Artificial Intelligence

WuXi AppTec Research Service Division and Cyclica Collaborate to Drive Polypharmacology in Drug Discovery Through AI-Augmented Technologies

WuXi AppTec

Drug Approval

WuXi STA First CDMO to Support the Approval of an Innovative Drug in China Through the "MAH" Pilot

WuXi AppTec

Artificial Intelligence

WuXi AppTec Leads Strategic Investment in Insilico Medicine to Accelerate Drug Discovery Using Next-Generation Artificial Intelligence

WuXi AppTec

IPO

WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange

WuXi AppTec

Expanded Capacity

WuXi STA to Build a New R&D Center in Shanghai

WuXi AppTec

Expanded Capacity

WuXi AppTec Expands Site in the U.S. for Drug Development Testing Services

WuXi AppTec

Partnership

Nohla Therapeutics Selects Advanced Therapies Business Unit of WuXi AppTec to Manufacture Universal Donor Cell Therapies

WuXi AppTec

Genomics

WuXi NextCODE Unveils Genomics Partnership with Google Cloud

WuXi NextCODE